SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.40 Cr | ₹1.40 Cr | - | ₹1.40 Cr | - |
What is the latest Contingent Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.40 Cr |
| Mar2024 | ₹1.40 Cr |
| Mar2023 | - |
| Mar2022 | ₹1.40 Cr |
| Mar2021 | - |
How is Contingent Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.40 Cr | 0.00 | |
| Mar2024 | ₹1.40 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹1.40 Cr | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,954.0 Cr | 0.8% | 47.2% | 84.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 0.8% |
47.2% |
84.4% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses